Miro E. Raeber
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
Papers in
- Immunology 15
- Immune Cell Function and Interaction 10
- Immunotherapy and Immune Responses 8
- T-cell and B-cell Immunology 8
-
- COVID-19 Clinical Research Studies 6
- SARS-CoV-2 and COVID-19 Research 6
- Co-authors
- Onur Boyman (24 shared papers)Yves Zurbuchen (12 shared papers)Daniela Impellizzieri (2 shared papers)Dilara Şahin (3 shared papers)Ufuk Karakus (3 shared papers)Sarah Adamo (10 shared papers)Carlo Cervia (10 shared papers)Jakob Nilsson (9 shared papers)
- Journals
- Allergy (3 papers)Nature Communications (3 papers)Nature Immunology (2 papers)Science Translational Medicine (2 papers)Nature (2 papers)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Miro E. Raeber
23 papers receiving 1.6k citations
Miro E. Raeber's Hit Papers
Peers
Comparison fields: 5 of 92
- Immunology 856
- Oncology 466
- Infectious Diseases 303
- Neurology 229
- Biological Psychiatry 22
Countries citing papers authored by Miro E. Raeber
This map shows the geographic impact of Miro E. Raeber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miro E. Raeber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miro E. Raeber more than expected).
Fields of papers citing papers by Miro E. Raeber
This network shows the impact of papers produced by Miro E. Raeber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miro E. Raeber. The network helps show where Miro E. Raeber may publish in the future.
Co-authors
The 25 scholars most cited alongside Miro E. Raeber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 429 | |
| 2 | 2018 | 167 | |
| 3 | Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome Hit paper breakdown → | 2022 | 143 |
| 4 | A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases Hit paper breakdown → | 2023 | 117 |
| 5 | 2021 | 92 | |
| 6 | 2020 | 86 | |
| 7 | 2019 | 70 | |
| 8 | 2020 | 69 | |
| 9 | 2022 | 60 | |
| 10 | 2021 | 55 | |
| 11 | 2015 | 43 | |
| 12 | 2018 | 42 | |
| 13 | 2022 | 41 | |
| 14 | 2014 | 39 | |
| 15 | 2022 | 34 | |
| 16 | 2024 | 31 | |
| 17 | 2023 | 24 | |
| 18 | 2020 | 22 | |
| 19 | 2021 | 14 | |
| 20 | 2022 | 5 |
About Miro E. Raeber
Miro E. Raeber is a scholar working on Immunology, Infectious Diseases, Neurology, Oncology and Rheumatology, having authored 25 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (10 papers), Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (8 papers), COVID-19 Clinical Research Studies (6 papers), SARS-CoV-2 and COVID-19 Research (6 papers), Long-Term Effects of COVID-19 (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Immunology (856 citations), Oncology (466 citations), Infectious Diseases (303 citations), Neurology (229 citations) and Biological Psychiatry (22 citations). Miro E. Raeber has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Onur Boyman, Yves Zurbuchen, Daniela Impellizzieri, Dilara Şahin, Ufuk Karakus, Sarah Adamo, Carlo Cervia, Jakob Nilsson, D.L. Bates and Vijay S. Pande. Their work appears in journals such as Allergy, Nature Communications, Nature Immunology, Science Translational Medicine and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.